This complex interaction between sex hormones, GH signaling and liver steatosis may converge on Cux2 contributing to the perturbation of sex-biased gene expression, such as that of Fmo3 and Acot3, in all four mice models of NAFLD tested herein. The gene discussed is CUX2; the disease is metabolic dysfunction-associated steatotic liver disease.